Entrada Therapeutics, Inc. — Institutional Ownership

Which tracked institutions hold TRDA, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.

18
Funds holding
$69992409
Total value held
Buying
12 added/new · 4 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Blackrock, Inc. $29767968 2358793 +211533 +9.85%
2 Merck & Co., Inc. $21955872 1739768 Held
3 State Street Corp $6736531 533798 +25009 +4.92%
4 Northern Trust Corp $2965599 234992 +8691 +3.84%
5 Goldman Sachs Group Inc $2685287 212780 +7607 +3.71%
6 Morgan Stanley $2222710 176126 -84125 -32.32%
7 Bank Of New York Mellon Corp $964509 76427 -2948 -3.71%
8 Ameriprise Financial Inc $886934 70280 -14613 -17.21%
9 Bank Of America Corp /De/ $494855 39212 -26767 -40.57%
10 Invesco Ltd. $421819 41033 +11958 +41.13%
11 Barclays Plc $361892 28676 NEW BUY
12 Wells Fargo & Company/Mn $330636 32163 +10547 +48.79%
13 Franklin Resources Inc $140107 11102 NEW BUY
14 Citigroup Inc $42394 4124 +2075 +101.27%
15 Pnc Financial Services Group, Inc. $14400 1141 Held
16 Us Bancorp \De\ $883 70 NEW BUY
17 Amalgamated Financial Corp. $13 1350 NEW BUY
18 Royal Bank Of Canada $0 25 NEW BUY

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.